Trace Biosciences files Form D covering $16.2 million equity offering
The Delaware biotech, based in Beaverton, Oregon, disclosed it has sold about half of a planned equity raise from 19 investors.
SEC filing
Latest
1 story
Sign inSign in1 story
The Delaware biotech, based in Beaverton, Oregon, disclosed it has sold about half of a planned equity raise from 19 investors.
SEC filing